Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allient Inc. stock logo
ALNT
Allient
$29.88
-1.8%
$23.91
$16.91
$32.95
$505.84M1.39116,859 shs109,429 shs
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$5.68
+1.4%
$5.82
$3.91
$13.99
$390.85M1.58814,541 shs368,862 shs
Quanterix Co. stock logo
QTRX
Quanterix
$4.85
+0.4%
$5.64
$4.05
$19.18
$188.32M1.12572,158 shs409,846 shs
Transcat, Inc. stock logo
TRNS
Transcat
$91.32
-0.3%
$79.46
$67.56
$147.12
$850.10M0.6981,969 shs70,643 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allient Inc. stock logo
ALNT
Allient
-1.84%-7.20%+41.61%+12.02%+5.84%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
+1.43%-7.34%-15.35%-7.64%-50.48%
Quanterix Co. stock logo
QTRX
Quanterix
+0.41%+1.25%-9.18%-35.76%-71.35%
Transcat, Inc. stock logo
TRNS
Transcat
-0.34%+12.39%+9.40%+14.36%-35.77%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allient Inc. stock logo
ALNT
Allient
2.639 of 5 stars
1.33.01.70.03.52.52.5
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
2.0859 of 5 stars
3.52.00.00.03.31.70.0
Quanterix Co. stock logo
QTRX
Quanterix
1.6924 of 5 stars
3.32.00.00.01.41.70.6
Transcat, Inc. stock logo
TRNS
Transcat
1.2178 of 5 stars
2.31.00.00.02.11.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allient Inc. stock logo
ALNT
Allient
2.50
Moderate Buy$31.003.75% Upside
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
3.00
Buy$25.38346.74% Upside
Quanterix Co. stock logo
QTRX
Quanterix
2.50
Moderate Buy$15.60221.65% Upside
Transcat, Inc. stock logo
TRNS
Transcat
2.50
Moderate Buy$114.0024.84% Upside

Current Analyst Ratings Breakdown

Latest QTRX, TRNS, ALNT, and EYPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2025
Transcat, Inc. stock logo
TRNS
Transcat
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$106.00 ➝ $116.00
5/16/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$30.00 ➝ $26.00
5/13/2025
Quanterix Co. stock logo
QTRX
Quanterix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
5/8/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $27.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$35.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
4/30/2025
Quanterix Co. stock logo
QTRX
Quanterix
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/30/2025
Quanterix Co. stock logo
QTRX
Quanterix
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$12.00 ➝ $8.00
3/25/2025
Quanterix Co. stock logo
QTRX
Quanterix
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
3/25/2025
Quanterix Co. stock logo
QTRX
Quanterix
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Outperform ➝ Sector Outperform$28.00 ➝ $18.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allient Inc. stock logo
ALNT
Allient
$516.06M0.98$4.36 per share6.86$15.52 per share1.93
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$56.04M6.97N/AN/A$5.66 per share1.00
Quanterix Co. stock logo
QTRX
Quanterix
$133.92M1.41N/AN/A$9.25 per share0.52
Transcat, Inc. stock logo
TRNS
Transcat
$278.42M3.05$3.36 per share27.14$30.19 per share3.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allient Inc. stock logo
ALNT
Allient
$24.10M$0.5933.9516.33N/A2.64%10.80%4.75%8/6/2025 (Estimated)
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$70.79M-$2.41N/AN/AN/A-226.57%-43.01%-31.63%8/6/2025 (Estimated)
Quanterix Co. stock logo
QTRX
Quanterix
-$28.35M-$1.30N/AN/AN/A-30.12%-11.74%-9.66%N/A
Transcat, Inc. stock logo
TRNS
Transcat
$13.65M$1.5649.3634.72N/A6.22%7.23%5.67%8/4/2025 (Estimated)

Latest QTRX, TRNS, ALNT, and EYPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/19/2025Q4 2025
Transcat, Inc. stock logo
TRNS
Transcat
$0.66$0.64-$0.02$0.48$76.40 million$77.13 million
5/12/2025Q1 2025
Quanterix Co. stock logo
QTRX
Quanterix
-$0.69-$0.53+$0.16-$0.53$28.27 million$30.33 million
5/7/2025Q1 2025
Allient Inc. stock logo
ALNT
Allient
$0.33$0.46+$0.13$0.21$125.00 million$134.62 million
5/7/2025Q1 2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$0.65-$0.65N/A-$0.65$8.84 million$24.50 million
3/17/2025Q4 2024
Quanterix Co. stock logo
QTRX
Quanterix
-$0.27-$0.30-$0.03-$0.30$34.93 million$35.16 million
3/5/2025Q4 2024
Allient Inc. stock logo
ALNT
Allient
$0.28$0.31+$0.03$0.18$119.72 million$122.01 million
3/5/2025Q4 2024
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$0.54-$0.64-$0.10-$0.64$11.02 million$11.60 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allient Inc. stock logo
ALNT
Allient
$0.120.40%+4.55%20.34%N/A
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
N/AN/AN/AN/AN/A
Quanterix Co. stock logo
QTRX
Quanterix
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A

Latest QTRX, TRNS, ALNT, and EYPT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.4%5/22/20255/22/20256/5/2025
3/5/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.51%3/20/20253/20/20254/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allient Inc. stock logo
ALNT
Allient
0.85
4.10
2.18
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
N/A
5.50
5.45
Quanterix Co. stock logo
QTRX
Quanterix
N/A
10.07
9.16
Transcat, Inc. stock logo
TRNS
Transcat
0.14
2.42
1.98

Institutional Ownership

CompanyInstitutional Ownership
Allient Inc. stock logo
ALNT
Allient
61.57%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
99.41%
Quanterix Co. stock logo
QTRX
Quanterix
86.48%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Allient Inc. stock logo
ALNT
Allient
14.90%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
4.74%
Quanterix Co. stock logo
QTRX
Quanterix
6.90%
Transcat, Inc. stock logo
TRNS
Transcat
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allient Inc. stock logo
ALNT
Allient
1,95016.93 million14.22 millionOptionable
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
12068.81 million65.02 millionOptionable
Quanterix Co. stock logo
QTRX
Quanterix
46038.83 million35.87 millionOptionable
Transcat, Inc. stock logo
TRNS
Transcat
9209.31 million9.10 millionOptionable

Recent News About These Companies

Transcat (NASDAQ:TRNS) Given Buy Rating at HC Wainwright
What is Northland Capmk's Forecast for Transcat Q1 Earnings?
What is HC Wainwright's Forecast for Transcat Q4 Earnings?
Transcat (NASDAQ:TRNS) Upgraded at Wall Street Zen
Transcat, Inc. stock logo
Transcat (TRNS) to Release Earnings on Monday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Allient stock logo

Allient NASDAQ:ALNT

$29.88 -0.56 (-1.84%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$29.88 +0.01 (+0.02%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

EyePoint Pharmaceuticals stock logo

EyePoint Pharmaceuticals NASDAQ:EYPT

$5.68 +0.08 (+1.43%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$5.60 -0.08 (-1.41%)
As of 05/23/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Quanterix stock logo

Quanterix NASDAQ:QTRX

$4.85 +0.02 (+0.41%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$4.85 0.00 (0.00%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Transcat stock logo

Transcat NASDAQ:TRNS

$91.32 -0.31 (-0.34%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$91.26 -0.06 (-0.07%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.